Another factor is blood sugar
From diet and exercise plans to the latest weight loss medications, we have the tools and expertise to help you reach your optimal health
GLP-1 receptor agonism results in reduction in hepatic ethanol metabolism
As for blood glucose, in one study, there was no difference between the Eriomin and placebo takers after 12 weeks
In addition to providing recommendations for achieving glycaemic control, current type 2 diabetes guidelines emphasise the importance of weight loss through lifestyle changes, surgical interventions or medications [6, 7]
Accessing GLP-1 receptor agonists specifically for fatty liver disease on the NHS can be challenging, as current prescribing pathways are primarily designed for diabetes and weight management rather than liver disease alone